First Affiliated Hospital Of Zhejiang University
Clinical trials sponsored by First Affiliated Hospital Of Zhejiang University, explained in plain language.
-
New pill shows promise for deadly Post-Transplant blood disorder
Disease control Not yet recruitingThis study tests a new pill, iptacopan, for a rare but serious blood vessel condition called TA-TMA that can happen after a stem cell transplant. The drug aims to block harmful immune system activity and protect blood vessels. About 30 people who have not responded to initial tre…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New 'shock and kill' therapy aims to flush out and destroy hidden HIV
Disease control Not yet recruitingThis study tests a two-step approach to target hidden HIV in the body. First, a drug called chidamide wakes up dormant HIV-infected cells. Then, specially designed natural killer (NK) cells are infused to find and kill those cells. The trial involves 20 adults with HIV who are st…
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
New combo procedure aims to fix aortic tears more completely
Disease control Not yet recruitingThis study tests a new way to treat a serious tear in the aorta (type B aortic dissection). The standard procedure uses a stent to close the main tear, but blood can still leak into a false channel, causing problems later. This study adds small plugs to block that false channel. …
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for brain stem bleeding: minimally invasive surgery tested in major trial
Disease control Not yet recruitingThis study tests if a precise, minimally invasive surgery (stereotactic aspiration) can improve outcomes for people with severe brain stem bleeding compared to standard medical care. The trial will enroll 300 adults with large hematomas and severe symptoms. The main goal is to se…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for Tough-to-Treat lymphoma: drug combo trial launches
Disease control Not yet recruitingThis study tests a new combination of drugs for adults with diffuse large B-cell lymphoma that has come back or not responded to standard treatments. The goal is to see if adding homoharringtonine and a BCL-2 inhibitor to rituximab and prednisone can safely shrink tumors. About 6…
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New scan could solve the mystery of hidden cancers
Diagnosis Not yet recruitingThis study tests a special PET scan (18F-FAPI) to locate the original source of cancers that have spread but have an unknown starting point. Researchers will enroll 120 people with suspected cancer of unknown primary to see how well this imaging method finds the primary tumor and…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 16, 2026 23:50 UTC
-
New scan duo could spot stomach cancer more accurately
Diagnosis Not yet recruitingThis study aims to see if combining a special PET scan (18F-FAPI) with detailed MRI can better diagnose and predict outcomes for people with gastric cancer. Researchers will enroll 230 patients suspected or diagnosed with gastric cancer. The goal is to improve how doctors detect …
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 13, 2026 16:00 UTC
-
New scan could sharpen detection of rare tumors
Diagnosis Not yet recruitingThis study will test a special PET scan (18F-Octreotide) to see if it can more accurately locate neuroendocrine tumors, guide treatment choices, and predict outcomes. About 152 adults with known or suspected neuroendocrine tumors will receive the scan. The goal is to improve diag…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 11, 2026 20:52 UTC
-
New scan could spot lung cancer more accurately
Diagnosis Not yet recruitingThis study will test a special type of PET/CT scan called 18F-FAPI to see how well it can find lung cancer and predict how the disease will progress. About 120 adults with lung cancer will receive the scan, and researchers will measure its accuracy and other imaging details. The …
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 11, 2026 20:39 UTC
-
Could a gut bug boost your mood? new trial tests probiotic for depression
Symptom relief Not yet recruitingThis study tests whether a probiotic called Bifidobacterium PB-18 can help adults with mild to moderate depression who are not taking antidepressants. About 88 people will take either the probiotic or a placebo daily for 8 weeks. Researchers will check if symptoms improve and exp…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Brain zaps may sharpen minds in bipolar disorder
Symptom relief Not yet recruitingThis study tests a noninvasive magnetic stimulation technique (TMS) targeting brain areas linked to memory and vision. 88 adults with bipolar disorder in a stable phase will receive either real or sham stimulation over 5 days. The goal is to see if this approach safely improves c…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Seaweed and fiber combo put to the test for better sleep
Symptom relief Not yet recruitingThis study tests whether taking inulin (a fiber) and spirulina (a type of algae) can improve sleep in adults aged 18 to 60 with chronic insomnia. 180 participants will be split into four groups: inulin alone, spirulina alone, both together, or a placebo. They will take the supple…
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Symptom relief
Last updated May 11, 2026 20:38 UTC
-
Which lung setting is safest during keyhole surgery? new study aims to find out.
Knowledge-focused Not yet recruitingThis study looks at 650 adults over 50 having keyhole lung surgery for early-stage lung cancer. During surgery, only one lung is ventilated, which can cause low oxygen and lung problems afterward. Researchers will test different breathing machine settings to see which leads to fe…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 16, 2026 23:38 UTC
-
New study tracks hidden pain after aortic surgery
Knowledge-focused Not yet recruitingThis study looks at the discomfort people feel after a procedure to fix a tear or bulge in the main artery (aorta). It will track 132 patients and measure things like back pain, skin irritation from tape, trouble moving, and stress. The goal is to better understand these issues s…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Brain wave study seeks to unlock secrets of anesthesia
Knowledge-focused Not yet recruitingThis study looks at brain wave patterns in 48 adults having arm or leg surgery under nerve blocks and sedation. Researchers want to see how different sedative drugs affect brain activity during unconsciousness and recovery. The goal is to better understand anesthesia, not to trea…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
Morning or evening? study tests best time for stem cell shots in donors
Knowledge-focused Not yet recruitingThis study looks at whether giving a daily G-CSF shot in the morning or evening helps healthy stem cell donors produce more cells for transplant. About 160 donors will be randomly assigned to receive the shot at 8 AM or 8 PM for 5 days. The goal is to find a simple schedule that …
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 05, 2026 11:52 UTC
-
A randomized, double-blind, placebo-controlled, prospective, multi-center trial evaluating the improvement of nutritional status and sarcopenia with silkworm pupa tablets in patients with malignancies
Not yet recruitingThis is a randomized, double-blind, placebo-controlled, parallel-group, prospective, multi-center clinical trial, to evaluate the efficacy of silkworm pupa tablets in improving nutritional status and sarcopenia in patients with malignancies who have completed comprehensive treatm…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University
Last updated May 11, 2026 20:49 UTC